Cargando…

Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR

PURPOSE: In January 2020, the COVID-19 pandemic started and has severely affected all countries around the world. The clinical symptoms alone are not sufficient for a proper diagnosis. Thus, molecular tests are required. Various institutes and researchers developed real-time PCR-based methods for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kia, Vahid, Tafti, Ali, Paryan, Mahdi, Mohammadi-Yeganeh, Samira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170118/
https://www.ncbi.nlm.nih.gov/pubmed/35668337
http://dx.doi.org/10.1007/s11845-022-03046-2
_version_ 1784721344735215616
author Kia, Vahid
Tafti, Ali
Paryan, Mahdi
Mohammadi-Yeganeh, Samira
author_facet Kia, Vahid
Tafti, Ali
Paryan, Mahdi
Mohammadi-Yeganeh, Samira
author_sort Kia, Vahid
collection PubMed
description PURPOSE: In January 2020, the COVID-19 pandemic started and has severely affected all countries around the world. The clinical symptoms alone are not sufficient for a proper diagnosis. Thus, molecular tests are required. Various institutes and researchers developed real-time PCR-based methods for the detection of the virus. However, the method needs expensive equipment. In the present study, we developed a real-time NASBA assay for the detection of SARS-CoV-2. METHODS: Primers and molecular beacon probes for RdRp and N genes were designed. In silico analysis showed that primers and the probes were specific for SARS-CoV-2. The standard samples with known copy numbers of the virus were tested using the NASBA assay and an FDA-approved real-time PCR kit. A series of standard samples were prepared and tested. Clinical sensitivity, precision analysis, and clinical assessment of the assay were performed. RESULTS: The limit of detection of the assay was 200 copies/mL. The clinical sensitivity of the assay was 97.64%. The intra-assay and inter-assay for both N and RdRp genes were less than 5% and 10%, respectively. Clinical assessment of the assay showed that the positive agreement rate and negative agreement rate of the assays were determined to be 97.64% and 100%, respectively. CONCLUSIONS: The results of the present study show that the developed real-time NASBA is a sensitive and specific method for the detection of SARS-CoV-2 and is comparable with real-time PCR. NASBA is an isothermal signal amplification method, and if stand-alone fluorescent readers are available, the real-time NASBA can be used without the need for expensive thermocyclers. In addition compared to other isothermal methods like LAMP, the primer design is straightforward. Thus, real-time NASBA could be a suitable method for inexpensive SARS-CoV-2 detection. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11845-022-03046-2.
format Online
Article
Text
id pubmed-9170118
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-91701182022-06-07 Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR Kia, Vahid Tafti, Ali Paryan, Mahdi Mohammadi-Yeganeh, Samira Ir J Med Sci Original Article PURPOSE: In January 2020, the COVID-19 pandemic started and has severely affected all countries around the world. The clinical symptoms alone are not sufficient for a proper diagnosis. Thus, molecular tests are required. Various institutes and researchers developed real-time PCR-based methods for the detection of the virus. However, the method needs expensive equipment. In the present study, we developed a real-time NASBA assay for the detection of SARS-CoV-2. METHODS: Primers and molecular beacon probes for RdRp and N genes were designed. In silico analysis showed that primers and the probes were specific for SARS-CoV-2. The standard samples with known copy numbers of the virus were tested using the NASBA assay and an FDA-approved real-time PCR kit. A series of standard samples were prepared and tested. Clinical sensitivity, precision analysis, and clinical assessment of the assay were performed. RESULTS: The limit of detection of the assay was 200 copies/mL. The clinical sensitivity of the assay was 97.64%. The intra-assay and inter-assay for both N and RdRp genes were less than 5% and 10%, respectively. Clinical assessment of the assay showed that the positive agreement rate and negative agreement rate of the assays were determined to be 97.64% and 100%, respectively. CONCLUSIONS: The results of the present study show that the developed real-time NASBA is a sensitive and specific method for the detection of SARS-CoV-2 and is comparable with real-time PCR. NASBA is an isothermal signal amplification method, and if stand-alone fluorescent readers are available, the real-time NASBA can be used without the need for expensive thermocyclers. In addition compared to other isothermal methods like LAMP, the primer design is straightforward. Thus, real-time NASBA could be a suitable method for inexpensive SARS-CoV-2 detection. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11845-022-03046-2. Springer International Publishing 2022-06-06 2023 /pmc/articles/PMC9170118/ /pubmed/35668337 http://dx.doi.org/10.1007/s11845-022-03046-2 Text en © The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Kia, Vahid
Tafti, Ali
Paryan, Mahdi
Mohammadi-Yeganeh, Samira
Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR
title Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR
title_full Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR
title_fullStr Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR
title_full_unstemmed Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR
title_short Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR
title_sort evaluation of real-time nasba assay for the detection of sars-cov-2 compared with real-time pcr
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170118/
https://www.ncbi.nlm.nih.gov/pubmed/35668337
http://dx.doi.org/10.1007/s11845-022-03046-2
work_keys_str_mv AT kiavahid evaluationofrealtimenasbaassayforthedetectionofsarscov2comparedwithrealtimepcr
AT taftiali evaluationofrealtimenasbaassayforthedetectionofsarscov2comparedwithrealtimepcr
AT paryanmahdi evaluationofrealtimenasbaassayforthedetectionofsarscov2comparedwithrealtimepcr
AT mohammadiyeganehsamira evaluationofrealtimenasbaassayforthedetectionofsarscov2comparedwithrealtimepcr